Patient 5 was a 59‐year‐old woman, not receiving any DMD for MS, who presented ALT abnormality (48 IU/L) 2 weeks after pulsed methylprednisolone therapy, reaching a peak of 838 IU/L 3 months later, while she remained asymptomatic. This evidence concerns the gene GPT and myeloid sarcoma.